These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12053928)

  • 41. Current resistance patterns of Staphylococcus aureus towards topical antibiotics and relevant antiseptics in patients with atopic dermatitis and impetigo.
    Thum D; Seidl HP; Hein R; Ring J; Andres C; Mempel M
    J Dtsch Dermatol Ges; 2013 Sep; 11(9):875-8. PubMed ID: 23621472
    [No Abstract]   [Full Text] [Related]  

  • 42. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK.
    Ravenscroft JC; Layton A; Barnham M
    Clin Exp Dermatol; 2000 Jun; 25(4):327-30. PubMed ID: 10971497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical inquiry: what is the best treatment for impetigo ?
    Shim J; Lanier J; Qui MK
    J Fam Pract; 2014 Jun; 63(6):333-5. PubMed ID: 25061625
    [No Abstract]   [Full Text] [Related]  

  • 44. Resistance of Staphylococcus aureus to fusidic acid.
    Peeters KA; Mascini EM; Sanders CJ
    Int J Dermatol; 2004 Mar; 43(3):235-6. PubMed ID: 15009402
    [No Abstract]   [Full Text] [Related]  

  • 45. Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections.
    Johnston C
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):797-8. PubMed ID: 1907980
    [No Abstract]   [Full Text] [Related]  

  • 46. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
    Memikoğlu KO; Bayar B; Kurt O; Cokça F
    Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Studies on staphylococcal coagulase type and phage type isolated from pyodermas, especially impetigo contagiosa].
    Uragami K
    Nihon Hifuka Gakkai Zasshi; 1983 May; 93(6):613-27. PubMed ID: 6225887
    [No Abstract]   [Full Text] [Related]  

  • 48. [Outburst of fusidic acid resistant Staphylococcus aureus].
    Kanazaki H; Akiyama H; Kanamoto A; Abe Y; Yamada T; Arata J; Umemura S; Ikeda M
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(4):507-10. PubMed ID: 2614994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fusidic acid in dermatology.
    Wilkinson JD
    Br J Dermatol; 1998 Dec; 139 Suppl 53():37-40. PubMed ID: 9990411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bacteriological studies in the therapy of treatment-resistant staphylococcal infections with fusidic acid].
    Roser H
    Med Welt; 1967 May; 21():1325-9. PubMed ID: 5612546
    [No Abstract]   [Full Text] [Related]  

  • 51. Impetigo: etiology and therapy.
    Hirschmann JV
    Curr Clin Top Infect Dis; 2002; 22():42-51. PubMed ID: 12520646
    [No Abstract]   [Full Text] [Related]  

  • 52. Antibiotic susceptibility of community-acquired Staphylococcus aureus.
    Tan Heng Soon ; Ngeow Yun Fong ; Farida Jamal
    Med J Malaysia; 1986 Mar; 41(1):24-9. PubMed ID: 3796343
    [No Abstract]   [Full Text] [Related]  

  • 53. Hydrogen peroxide cream: an alternative to topical antibiotics in the treatment of impetigo contagiosa.
    Christensen OB; Anehus S
    Acta Derm Venereol; 1994 Nov; 74(6):460-2. PubMed ID: 7701881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A blistering child: a toddler with large bullae.
    Mohme S; Goebeler M; Hamm H
    Eur J Dermatol; 2021 Dec; 31(6):853-855. PubMed ID: 35107079
    [No Abstract]   [Full Text] [Related]  

  • 55. Antibiotic susceptibilities of Staphylococcus aureus strains derived from furuncle and bullous impetigo.
    Dekio S; Hirata T; Jidoi J; Ozasa S; Ohno H
    J Dermatol; 1985 Feb; 12(1):47-51. PubMed ID: 3894459
    [No Abstract]   [Full Text] [Related]  

  • 56. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
    Lemaire S; Van Bambeke F; Pierard D; Appelbaum PC; Tulkens PM
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S493-503. PubMed ID: 21546626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fusidic acid resistance, mediated by fusB, in bovine coagulase-negative staphylococci.
    Yazdankhah SP; Asli AW; Sørum H; Oppegaard H; Sunde M
    J Antimicrob Chemother; 2006 Dec; 58(6):1254-6. PubMed ID: 17060340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of primary care data for detecting impetigo trends, United kingdom, 1995-2010.
    Shallcross LJ; Petersen I; Rosenthal J; Johnson AM; Freemantle N; Hayward AC
    Emerg Infect Dis; 2013 Oct; 19(10):1646-8. PubMed ID: 24047615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High levels of fusidic acid-resistant Staphylococcus aureus despite restrictions on antibiotic use.
    Mitra A; Mohanraj M; Shah M
    Clin Exp Dermatol; 2009 Mar; 34(2):136-9. PubMed ID: 18828847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fusidic acid as a potential antistaphylococcal agent.
    Nicholson J; Chew T; Smith S
    N Z Med J; 1999 Jul; 112(1091):261-2. PubMed ID: 10448991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.